Calliditas Therapeutics AB (publ) CALT
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 2.15B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 6.33
- Beta
- 1.46
- Short ratio
- 0.30
- Inst. own
- 0.32%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 11, 2024
- 50-d avg
- 39.65
- 200-d avg
- 29.60
- 1y target
- 39.25
MAX chart
Chart tools
Chart is warming up
The all-time price history for CALT has not been loaded yet. Try again in a moment.
Altman Z-Score
8.46 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -14.9×
P/S 5.8×
P/B 20.8×
P/FCF -15.5×
EV/EBITDA -18.9×
EV/Sales 5.8×
FCF Yield -6.4%
Gross Margin 93.6%
Operating Margin -31.9%
Net Margin -38.6%
ROE -139.2%
ROIC -25.5%
ROA -24.5%
Revenue 50.3%
Operating Income 8.9%
EPS (diluted) -11.7%
Free Cash Flow -42.6%
Current Ratio 3.1×
Quick Ratio 3.1×
Debt / Equity 2.9×
Net Debt / EBITDA -0.0×
Interest Coverage -5.3×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2023-12-31